Clinical Trial Update: Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports on intensified azacitidine regimens in high-risk myelodysplastic syndrome, across Phase 1 and Phase 2, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: COMPLETED